Quantitative diagnostic methods using multiple parameters

Abstract

Materials and methods related to diagnosing a clinical condition in a subject, or determining the subject's predisposition to develop the clinical condition, using a multi-parameter system to measure a plurality of parameters and an algorithm to determine a disease score.

1 . A process for diagnosing a human subject as having or not having depression, comprising:
 (a) obtaining a measured level for each of epithelial growth factor (EGF), cortisol, and brain-derived neurotrophic factor (BDNF) in a blood or urine sample from the subject;   (b) comparing the measured levels with control levels of EGF, cortisol, and BDNF in blood or urine samples, respectively, from normal human subjects who do not have depression; and   (c) diagnosing the subject as having depression if (i) the measured levels of EGF and BDNF are lower than the control levels for EGF and BDNF and (ii) the measured level of cortisol is higher than the control level for cortisol, or diagnosing the subject as not having depression if (i) the measured levels of EGF and BDNF are not lower than the control levels for EGF and BDNF and (ii) the measured level of cortisol is not higher than the control level for cortisol.   
     
     
         2 . The process of  claim 1 , wherein said depression is a major depression disorder. 
     
     
         3 . The process of  claim 1 , wherein said blood sample is whole blood. 
     
     
         4 . The process of  claim 1 , wherein said blood sample is serum. 
     
     
         5 . The process of  claim 1 , wherein said blood sample is plasma. 
     
     
         6 . A process for classifying a human subject as having or not having depression, comprising:
 (a) performing an immunological assay to obtain a measured level for each of epithelial growth factor (EGF), cortisol, and brain-derived neurotrophic factor (BDNF) in a blood or urine sample from the subject;   (b) comparing the measured levels with control levels of EGF, cortisol, and BDNF in blood or urine samples, respectively, from normal human subjects who do not have depression; and   (c) classifying the subject as having depression if (i) the measured levels of EGF and BDNF are lower than the control levels for EGF and BDNF and (ii) the measured level of cortisol is higher than the control level for cortisol, or classifying the subject as not having depression if (i) the measured levels of EGF and BDNF are not lower than the control levels for EGF and BDNF and (ii) the measured level of cortisol is not higher than the control level for cortisol.   
     
     
         7 . The process of  claim 6 , wherein said depression is a major depression disorder. 
     
     
         8 . The process of  claim 6 , wherein said blood sample is whole blood. 
     
     
         9 . The process of  claim 6 , wherein said blood sample is serum. 
     
     
         10 . The process of  claim 6 , wherein said blood sample is plasma. 
     
     
         11 - 15 . (canceled)